AIM
MRNA icon

Aigen Investment Management’s Moderna MRNA Stock Holding History

Aigen Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,470
Closed -$293K – 908
2024
Q2 		$293K Buy
+2,470
New +$313K 0.06% 484
2023
Q3 		– Sell
-19,608
Closed -$2.38M – 988
2023
Q2 		$2.38M Buy
+19,608
New +$2.62M 0.35% 70
2022
Q1 		– Sell
-17,335
Closed -$4.85M – 880
2021
Q4 		$4.85M Buy
+17,335
New +$5.07M 0.3% 78
2021
Q2 		– Sell
-8,270
Closed -$1.08M – 637
2021
Q1 		$1.08M Buy
+8,270
New +$1.2M 0.14% 165

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aigen Investment Management's MRNA Position: Q3 2024 in Review

Aigen Investment Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,470 shares — an estimated $293K sold.

Aigen Investment Management first reported a position in MRNA in Q1 2021 and held it in 4 quarters. The position peaked at $4.85M in Q4 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Aigen Investment Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Aigen Investment Management sold 2,470 Moderna shares in Q3 2024, an estimated $293K.
  • Aigen Investment Management first reported a position in Moderna in Q1 2021 and held it in 4 quarters.
  • Aigen Investment Management's Moderna position peaked at $4.85M in Q4 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Aigen Investment Management's 13F filing for Q3 2024, filed 5 Nov 2024.